Monomethylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase

Chemical Research in Toxicology

Volumn 14, Issue 6, 2001, Pages 651-656

  Petrick, J S ^a   Jagadish, B ^b   Mash, E A ^b   Aposhian, H V ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; ARSENITE SODIUM; ARSINE DERIVATIVE; DIIODOMETHYLARSINE; METHANEARSONIC ACID; METHYLARSINE OXIDE; METHYLARSONOUS ACID; PYRUVATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HAMSTER; LD 50; MALE; NONHUMAN; TOXICITY;

EID: 0034974261     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000264z     Document Type: Article

References (33)

1. The enigma of arsenic carcinogenesis: Role of metabolism
2. Is the human carcinogen arsenic carcinogenic to laboratory animals?
3. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity
4. Biological methylation
5. Arsenic speciation in the environment
6. V reductase
7. The metabolism of methylarsine oxide and sulfide
8. III) is more toxic than arsenite in Chang human hepatocytes
9. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
10. III), excreted in human urine
11. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic
12. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue
13. Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats
14. Reactions of British anti-lewisite with arsenic and other metals in living systems
15. An analysis of the inhibition of pyruvate oxidation by arsenicals in relation to the enzyme theory of vessication
16. The chemistry and function of the pyruvate oxidation factor (lipoic acid)
17. 4]
18. A new type of compound containing arsenic
19. Optical isomers of 2,3-dimercapto-1-propanesulfonate: Antidotal activity, in vitro and in vivo, against sodium arsenite
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Inactivation and disassembly of the pyruvate dehydrogenase multienzyme complex from bovine kidney by limited proteolysis with an enzyme from rat liver
22. The enzymatic conversion of uracil 5-carboxylic acid to uracil and carbon dioxide
23. III) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes
24. The pharmacologic basis for the widely varying toxicity of arsenicals
25. DL- and mesodimercaptosuccinic acid: In vitro and in vivo studies with sodium arsenite
26. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols
27. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase
28. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes
29. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes
30. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits
31. Toxic effects of metals
32. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture